Introduction
Academic research in science and technology has been one of the main drivers in economic development, prosperity and dramatic improvement in public health in the developed countries. This is particularly evident in the 20 th century United States with the discovery of the transistors, microelectronics, microcomputers and the Internet in the telecommunications arena. In health sciences, the development of polio vaccine, antibiotics, and the advent of molecular biology, DNA structure, human genome and innovations in medical devices have revolutionized public health. Much of this discovery and development effort has strong roots in the basic science and technology research actively supported by the T government and the universities. For example, the development of the Silicon Valley and the biotech industries in California, Massachusetts, Washington, North Carolina and other states, are located around strong academic communities that promote venture capital and start up companies that have flourished since the 1950s.
The Institute for Advancing Medical Innovations (IAMI) currently in place at the University of Kansas (KU) is a bold step in this direction to promote translational research by the faculty and students which will contribute strongly to the economic development in Kansas and the Kansas City region. We anticipate that this effort in partnership with the Kauffman Foundation, Kansas Biosciences Authority (KBA) and regional animal and bioscience industry will promote entrepreneurship and economic development.
As shown in Figure 1 , IAMI supports Proof-of-Concept (POC) projects in drug discovery and delivery along with innovative approaches to drug-device development that can lead to commercialization through start up companies based on research funded at KU. Partnerships will be entertained and encouraged with national and international universities, companies and philanthropic organizations to deliver life-saving products to patients. Revenues from these activities will be used to fund translational research at KU and in the Kansas City region. Figure 2 illustrates an idea that starts on pieces of paper and a test tube on the basis of basic science research supported by federal and philanthropic research grants. Scientists drive these ideas and projects through various stages of early development that mostly result in significant scientific publications and serve to train students and post-doctoral scientists. Many of the discoveries, when carefully evaluated, may have benefit for patients and the public and require rigorous research development activities before commercialization. Work needs to be done in in-vivo animal studies and then in expensive human clinical trials with appropriate product type (formulation, device etc.) to advance discoveries to the patients and the public.
In Note that prior to the establishment of IAMI, the Office of Therapeutics and Drug Development (OTDD) lead by Dr. Scott Weir promoted three projects that are in the clinic as shown in Figure 2 . Nanotax® is nano-crystalline form of Paclitaxel for ovarian cancer that is currently in Phase I at the University of Kansas Cancer Center, and was a KU innovation to minimize side effects in the current marketed formulation. The Ciclopirox Olamine is a project to support a blood cancer therapy with the The requirements for selecting POC projects are shown in Table 1 . Once the request for proposals (RFP) are announced within KU, principal investigators and students submit a letter of intent (LOI) to IAMI and meet with project managers to plan the preparation of the grant proposals. Note that the criteria described in the Table below strongly encourage applicants to submit relevant information on their science, technology, intellectual property and commercialization potential. These proposals are, therefore, quite different from other basic science grant applications. Both the faculty and students learn many aspects of innovation and commercialization that are not part of normal university curriculum.
• Medical innovation novelty (unmet need) 
IAMI Fellows Training Program
As part of its commitment to the educational mission of the university and training entrepreneurs, IAMI funds fellowships for 10 graduate students and 4 post-doctoral scientists at KU on an yearly basis. One additional post-doctoral scientist is funded at the Kauffman National Fellowships program through IAMI. The Fellows come from business school, chemistry, biology, engineering and related programs at KU, and have projects that are innovative. They are required to attend regular group meetings, meet with assigned adjunct instructors as mentors (Table 3) , and submit annual progress reports to the IAMI management and the advisory board. They are required to work with KU Business School to develop business plans and funding proposals for venture capital firms. This is a unique opportunity for the IAMI fellows to develop their science and technology and conceptualize their business plans. IAMI is an innovative idea to support faculty entrepreneurs and local and regional economy by leveraging industrial expertise to commercialize discoveries at KU. As shown in Figure 3 , by encouraging partnerships between researchers at both campuses and providing project management expertise, process re-engineering and training, we are fostering a culture of collaboration and innovation. An ultimate challenge in creating such models in the academic environment is its sustainability over the long term and its impact on the local and national economies. 
